Close monitoring of HIV viral load is crucial to prevent LLV among HIV-positive patients on ART, particularly older adults with low CD4+ counts and a history of PI use.

HIV-1 protease inhibitors are unique among anti-HIV-1 drugs in that they have very high potency and they also have a very high genetic barrier to resistance. The viral protease is essential in the ...

HIV’s Tat protein blocks autophagy in macrophages, letting Mtb thrive. This may explain why HIV patients face higher TB risk even on ART.

Researchers at the University of Washington and Fred Hutch found that CARD8, an inflammasome sensor, detects HIV-1 in macrophages during cell-to-cell viral transmissions from infected T cells. HIV can ...

The stock-trading website Raging Bull just gave Cocrystal Pharma, a clinical-stage biotech, a big thumbs up for its ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

The FDA has granted accelerated approval to Jazz Pharmaceuticals’ dordaviprone (Modeyso) for the treatment of patients with diffuse midline gliomas that harbour H3 K27M mutations who have progressive ...

As the annual U.S. Conference on HIV/AIDS (USCHA) kicks off in Washington, D.C., this week with a focus on aging with HIV, Gilead Sciences is rolling out a corresponding awareness campaign ...

The European Commission has formally approved a twice-yearly injection to prevent HIV, clearing the way for the jab to be rolled out across the European Union, according to drugmaker Gilead. The ...

Meeting UNAIDS’ “95/95/95” targets for 2025—95% of people with HIV knowing their status, 95% of those who know their status on treatment, and 95% of people on treatment having a suppressed viral ...

Sara Herschander is a fellow for Future Perfect, Vox’s section on making the world a better place. She writes about global health, philanthropy, labor, and social movements. Botswana has been getting ...

The plan to target pregnant and breastfeeding mothers will be administered through the President’s Emergency Plan for AIDS Relief. Critics said it appeared to sidestep LGBTQ+ people. The Trump ...